nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—superior mesenteric artery—colon cancer	0.194	0.561	CbGeAlD
Octreotide—SSTR4—digestive system—colon cancer	0.0288	0.0833	CbGeAlD
Octreotide—SSTR2—renal system—colon cancer	0.0193	0.0557	CbGeAlD
Octreotide—MPO—endothelium—colon cancer	0.0175	0.0506	CbGeAlD
Octreotide—MPO—blood vessel—colon cancer	0.0162	0.0467	CbGeAlD
Octreotide—SSTR2—digestive system—colon cancer	0.0158	0.0457	CbGeAlD
Octreotide—SSTR1—liver—colon cancer	0.0138	0.04	CbGeAlD
Octreotide—MPO—epithelium—colon cancer	0.00786	0.0227	CbGeAlD
Octreotide—MPO—renal system—colon cancer	0.00729	0.0211	CbGeAlD
Octreotide—MPO—lymphoid tissue—colon cancer	0.00605	0.0175	CbGeAlD
Octreotide—MPO—digestive system—colon cancer	0.00598	0.0173	CbGeAlD
Octreotide—MPO—bone marrow—colon cancer	0.00551	0.0159	CbGeAlD
Octreotide—MPO—liver—colon cancer	0.00446	0.0129	CbGeAlD
Octreotide—MPO—lymph node—colon cancer	0.00342	0.00988	CbGeAlD
Octreotide—Anaemia—Fluorouracil—colon cancer	0.00112	0.00171	CcSEcCtD
Octreotide—Loss of consciousness—Irinotecan—colon cancer	0.00111	0.0017	CcSEcCtD
Octreotide—Myalgia—Vincristine—colon cancer	0.0011	0.00169	CcSEcCtD
Octreotide—Weight increased—Capecitabine—colon cancer	0.0011	0.00169	CcSEcCtD
Octreotide—Visual disturbance—Methotrexate—colon cancer	0.0011	0.00169	CcSEcCtD
Octreotide—Cough—Irinotecan—colon cancer	0.0011	0.00168	CcSEcCtD
Octreotide—Weight decreased—Capecitabine—colon cancer	0.0011	0.00168	CcSEcCtD
Octreotide—Hyperglycaemia—Capecitabine—colon cancer	0.00109	0.00167	CcSEcCtD
Octreotide—Hypertension—Irinotecan—colon cancer	0.00109	0.00167	CcSEcCtD
Octreotide—Pneumonia—Capecitabine—colon cancer	0.00109	0.00166	CcSEcCtD
Octreotide—Anaphylactoid reaction—Methotrexate—colon cancer	0.00108	0.00165	CcSEcCtD
Octreotide—Depression—Capecitabine—colon cancer	0.00108	0.00165	CcSEcCtD
Octreotide—Discomfort—Irinotecan—colon cancer	0.00106	0.00162	CcSEcCtD
Octreotide—Neuropathy peripheral—Capecitabine—colon cancer	0.00106	0.00162	CcSEcCtD
Octreotide—Oedema—Vincristine—colon cancer	0.00106	0.00162	CcSEcCtD
Octreotide—Anaphylactic shock—Vincristine—colon cancer	0.00106	0.00162	CcSEcCtD
Octreotide—Jaundice—Capecitabine—colon cancer	0.00105	0.00161	CcSEcCtD
Octreotide—Infection—Vincristine—colon cancer	0.00105	0.00161	CcSEcCtD
Octreotide—Urinary tract infection—Capecitabine—colon cancer	0.00105	0.00161	CcSEcCtD
Octreotide—Conjunctivitis—Capecitabine—colon cancer	0.00105	0.00161	CcSEcCtD
Octreotide—Convulsion—Fluorouracil—colon cancer	0.00105	0.0016	CcSEcCtD
Octreotide—Osteoarthritis—Methotrexate—colon cancer	0.00104	0.0016	CcSEcCtD
Octreotide—Nervous system disorder—Vincristine—colon cancer	0.00104	0.00159	CcSEcCtD
Octreotide—Thrombocytopenia—Vincristine—colon cancer	0.00104	0.00158	CcSEcCtD
Octreotide—Haematuria—Capecitabine—colon cancer	0.00103	0.00158	CcSEcCtD
Octreotide—Anaphylactic shock—Irinotecan—colon cancer	0.00103	0.00158	CcSEcCtD
Octreotide—Oedema—Irinotecan—colon cancer	0.00103	0.00158	CcSEcCtD
Octreotide—Myalgia—Fluorouracil—colon cancer	0.00103	0.00157	CcSEcCtD
Octreotide—Chest pain—Fluorouracil—colon cancer	0.00103	0.00157	CcSEcCtD
Octreotide—Infection—Irinotecan—colon cancer	0.00102	0.00157	CcSEcCtD
Octreotide—Hyperhidrosis—Vincristine—colon cancer	0.00102	0.00156	CcSEcCtD
Octreotide—Hepatobiliary disease—Capecitabine—colon cancer	0.00102	0.00156	CcSEcCtD
Octreotide—Epistaxis—Capecitabine—colon cancer	0.00102	0.00156	CcSEcCtD
Octreotide—Discomfort—Fluorouracil—colon cancer	0.00102	0.00156	CcSEcCtD
Octreotide—Shock—Irinotecan—colon cancer	0.00101	0.00155	CcSEcCtD
Octreotide—Nervous system disorder—Irinotecan—colon cancer	0.00101	0.00155	CcSEcCtD
Octreotide—Thrombocytopenia—Irinotecan—colon cancer	0.00101	0.00154	CcSEcCtD
Octreotide—Anorexia—Vincristine—colon cancer	0.00101	0.00154	CcSEcCtD
Octreotide—Irritability—Methotrexate—colon cancer	0.000997	0.00152	CcSEcCtD
Octreotide—Hyperhidrosis—Irinotecan—colon cancer	0.000996	0.00152	CcSEcCtD
Octreotide—Bradycardia—Capecitabine—colon cancer	0.000989	0.00151	CcSEcCtD
Octreotide—Oedema—Fluorouracil—colon cancer	0.000987	0.00151	CcSEcCtD
Octreotide—Anaphylactic shock—Fluorouracil—colon cancer	0.000987	0.00151	CcSEcCtD
Octreotide—Anorexia—Irinotecan—colon cancer	0.000983	0.0015	CcSEcCtD
Octreotide—Infection—Fluorouracil—colon cancer	0.000981	0.0015	CcSEcCtD
Octreotide—Rhinitis—Capecitabine—colon cancer	0.000973	0.00149	CcSEcCtD
Octreotide—Hepatitis—Capecitabine—colon cancer	0.000971	0.00148	CcSEcCtD
Octreotide—Nervous system disorder—Fluorouracil—colon cancer	0.000968	0.00148	CcSEcCtD
Octreotide—Thrombocytopenia—Fluorouracil—colon cancer	0.000967	0.00148	CcSEcCtD
Octreotide—Hypoaesthesia—Capecitabine—colon cancer	0.000966	0.00148	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000964	0.00147	CcSEcCtD
Octreotide—Pharyngitis—Capecitabine—colon cancer	0.000964	0.00147	CcSEcCtD
Octreotide—Tachycardia—Fluorouracil—colon cancer	0.000963	0.00147	CcSEcCtD
Octreotide—Insomnia—Vincristine—colon cancer	0.000957	0.00146	CcSEcCtD
Octreotide—Oedema peripheral—Capecitabine—colon cancer	0.000957	0.00146	CcSEcCtD
Octreotide—Paraesthesia—Vincristine—colon cancer	0.00095	0.00145	CcSEcCtD
Octreotide—Anorexia—Fluorouracil—colon cancer	0.000941	0.00144	CcSEcCtD
Octreotide—Visual impairment—Capecitabine—colon cancer	0.000936	0.00143	CcSEcCtD
Octreotide—Insomnia—Irinotecan—colon cancer	0.000932	0.00143	CcSEcCtD
Octreotide—Paraesthesia—Irinotecan—colon cancer	0.000926	0.00141	CcSEcCtD
Octreotide—Decreased appetite—Vincristine—colon cancer	0.00092	0.00141	CcSEcCtD
Octreotide—Dyspnoea—Irinotecan—colon cancer	0.000919	0.0014	CcSEcCtD
Octreotide—Somnolence—Irinotecan—colon cancer	0.000916	0.0014	CcSEcCtD
Octreotide—Gastrointestinal disorder—Vincristine—colon cancer	0.000914	0.0014	CcSEcCtD
Octreotide—Fatigue—Vincristine—colon cancer	0.000912	0.0014	CcSEcCtD
Octreotide—Dyspepsia—Irinotecan—colon cancer	0.000907	0.00139	CcSEcCtD
Octreotide—Tinnitus—Capecitabine—colon cancer	0.000905	0.00138	CcSEcCtD
Octreotide—Constipation—Vincristine—colon cancer	0.000905	0.00138	CcSEcCtD
Octreotide—Pain—Vincristine—colon cancer	0.000905	0.00138	CcSEcCtD
Octreotide—Asthma—Methotrexate—colon cancer	0.000903	0.00138	CcSEcCtD
Octreotide—Flushing—Capecitabine—colon cancer	0.000901	0.00138	CcSEcCtD
Octreotide—Cardiac disorder—Capecitabine—colon cancer	0.000901	0.00138	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000899	0.00138	CcSEcCtD
Octreotide—Decreased appetite—Irinotecan—colon cancer	0.000896	0.00137	CcSEcCtD
Octreotide—Insomnia—Fluorouracil—colon cancer	0.000893	0.00137	CcSEcCtD
Octreotide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00089	0.00136	CcSEcCtD
Octreotide—Fatigue—Irinotecan—colon cancer	0.000889	0.00136	CcSEcCtD
Octreotide—Paraesthesia—Fluorouracil—colon cancer	0.000886	0.00136	CcSEcCtD
Octreotide—Pancreatitis—Methotrexate—colon cancer	0.000885	0.00135	CcSEcCtD
Octreotide—Pain—Irinotecan—colon cancer	0.000881	0.00135	CcSEcCtD
Octreotide—Constipation—Irinotecan—colon cancer	0.000881	0.00135	CcSEcCtD
Octreotide—Dyspnoea—Fluorouracil—colon cancer	0.00088	0.00135	CcSEcCtD
Octreotide—Somnolence—Fluorouracil—colon cancer	0.000878	0.00134	CcSEcCtD
Octreotide—Immune system disorder—Capecitabine—colon cancer	0.000877	0.00134	CcSEcCtD
Octreotide—Dyspepsia—Fluorouracil—colon cancer	0.000869	0.00133	CcSEcCtD
Octreotide—Arrhythmia—Capecitabine—colon cancer	0.000867	0.00133	CcSEcCtD
Octreotide—Abdominal discomfort—Methotrexate—colon cancer	0.000866	0.00132	CcSEcCtD
Octreotide—Gastrointestinal pain—Vincristine—colon cancer	0.000865	0.00132	CcSEcCtD
Octreotide—Decreased appetite—Fluorouracil—colon cancer	0.000858	0.00131	CcSEcCtD
Octreotide—Alopecia—Capecitabine—colon cancer	0.000858	0.00131	CcSEcCtD
Octreotide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000852	0.0013	CcSEcCtD
Octreotide—Mental disorder—Capecitabine—colon cancer	0.000851	0.0013	CcSEcCtD
Octreotide—Feeling abnormal—Irinotecan—colon cancer	0.000849	0.0013	CcSEcCtD
Octreotide—Malnutrition—Capecitabine—colon cancer	0.000845	0.00129	CcSEcCtD
Octreotide—Erythema—Capecitabine—colon cancer	0.000845	0.00129	CcSEcCtD
Octreotide—Dysuria—Methotrexate—colon cancer	0.000844	0.00129	CcSEcCtD
Octreotide—Pain—Fluorouracil—colon cancer	0.000844	0.00129	CcSEcCtD
Octreotide—Gastrointestinal pain—Irinotecan—colon cancer	0.000843	0.00129	CcSEcCtD
Octreotide—Upper respiratory tract infection—Methotrexate—colon cancer	0.000839	0.00128	CcSEcCtD
Octreotide—Body temperature increased—Vincristine—colon cancer	0.000837	0.00128	CcSEcCtD
Octreotide—Abdominal pain—Vincristine—colon cancer	0.000837	0.00128	CcSEcCtD
Octreotide—Flatulence—Capecitabine—colon cancer	0.000833	0.00127	CcSEcCtD
Octreotide—Back pain—Capecitabine—colon cancer	0.000818	0.00125	CcSEcCtD
Octreotide—Body temperature increased—Irinotecan—colon cancer	0.000815	0.00125	CcSEcCtD
Octreotide—Abdominal pain—Irinotecan—colon cancer	0.000815	0.00125	CcSEcCtD
Octreotide—Feeling abnormal—Fluorouracil—colon cancer	0.000814	0.00124	CcSEcCtD
Octreotide—Muscle spasms—Capecitabine—colon cancer	0.000813	0.00124	CcSEcCtD
Octreotide—Pneumonia—Methotrexate—colon cancer	0.00081	0.00124	CcSEcCtD
Octreotide—Drowsiness—Methotrexate—colon cancer	0.000805	0.00123	CcSEcCtD
Octreotide—Depression—Methotrexate—colon cancer	0.000803	0.00123	CcSEcCtD
Octreotide—Vision blurred—Capecitabine—colon cancer	0.000797	0.00122	CcSEcCtD
Octreotide—Tremor—Capecitabine—colon cancer	0.000792	0.00121	CcSEcCtD
Octreotide—Ill-defined disorder—Capecitabine—colon cancer	0.000784	0.0012	CcSEcCtD
Octreotide—Urticaria—Fluorouracil—colon cancer	0.000784	0.0012	CcSEcCtD
Octreotide—Conjunctivitis—Methotrexate—colon cancer	0.000783	0.0012	CcSEcCtD
Octreotide—Anaemia—Capecitabine—colon cancer	0.000781	0.00119	CcSEcCtD
Octreotide—Body temperature increased—Fluorouracil—colon cancer	0.00078	0.00119	CcSEcCtD
Octreotide—Hypersensitivity—Vincristine—colon cancer	0.00078	0.00119	CcSEcCtD
Octreotide—Haematuria—Methotrexate—colon cancer	0.000768	0.00117	CcSEcCtD
Octreotide—Malaise—Capecitabine—colon cancer	0.000762	0.00117	CcSEcCtD
Octreotide—Hepatobiliary disease—Methotrexate—colon cancer	0.000762	0.00116	CcSEcCtD
Octreotide—Epistaxis—Methotrexate—colon cancer	0.000759	0.00116	CcSEcCtD
Octreotide—Vertigo—Capecitabine—colon cancer	0.000759	0.00116	CcSEcCtD
Octreotide—Hypersensitivity—Irinotecan—colon cancer	0.000759	0.00116	CcSEcCtD
Octreotide—Asthenia—Vincristine—colon cancer	0.000759	0.00116	CcSEcCtD
Octreotide—Syncope—Capecitabine—colon cancer	0.000758	0.00116	CcSEcCtD
Octreotide—Palpitations—Capecitabine—colon cancer	0.000747	0.00114	CcSEcCtD
Octreotide—Loss of consciousness—Capecitabine—colon cancer	0.000743	0.00114	CcSEcCtD
Octreotide—Asthenia—Irinotecan—colon cancer	0.00074	0.00113	CcSEcCtD
Octreotide—Cough—Capecitabine—colon cancer	0.000738	0.00113	CcSEcCtD
Octreotide—Hypertension—Capecitabine—colon cancer	0.00073	0.00112	CcSEcCtD
Octreotide—Hypersensitivity—Fluorouracil—colon cancer	0.000727	0.00111	CcSEcCtD
Octreotide—Diarrhoea—Vincristine—colon cancer	0.000724	0.00111	CcSEcCtD
Octreotide—Hepatitis—Methotrexate—colon cancer	0.000723	0.00111	CcSEcCtD
Octreotide—Chest pain—Capecitabine—colon cancer	0.00072	0.0011	CcSEcCtD
Octreotide—Arthralgia—Capecitabine—colon cancer	0.00072	0.0011	CcSEcCtD
Octreotide—Myalgia—Capecitabine—colon cancer	0.00072	0.0011	CcSEcCtD
Octreotide—Pharyngitis—Methotrexate—colon cancer	0.000717	0.0011	CcSEcCtD
Octreotide—Anxiety—Capecitabine—colon cancer	0.000717	0.0011	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000715	0.00109	CcSEcCtD
Octreotide—Discomfort—Capecitabine—colon cancer	0.000711	0.00109	CcSEcCtD
Octreotide—Diarrhoea—Irinotecan—colon cancer	0.000705	0.00108	CcSEcCtD
Octreotide—Dry mouth—Capecitabine—colon cancer	0.000704	0.00108	CcSEcCtD
Octreotide—Dizziness—Vincristine—colon cancer	0.0007	0.00107	CcSEcCtD
Octreotide—Pruritus—Fluorouracil—colon cancer	0.000698	0.00107	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—colon cancer	0.000697	0.00106	CcSEcCtD
Octreotide—Oedema—Capecitabine—colon cancer	0.00069	0.00105	CcSEcCtD
Octreotide—Infection—Capecitabine—colon cancer	0.000685	0.00105	CcSEcCtD
Octreotide—Dizziness—Irinotecan—colon cancer	0.000682	0.00104	CcSEcCtD
Octreotide—Shock—Capecitabine—colon cancer	0.000679	0.00104	CcSEcCtD
Octreotide—Nervous system disorder—Capecitabine—colon cancer	0.000677	0.00103	CcSEcCtD
Octreotide—Diarrhoea—Fluorouracil—colon cancer	0.000675	0.00103	CcSEcCtD
Octreotide—Thrombocytopenia—Capecitabine—colon cancer	0.000675	0.00103	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—colon cancer	0.000674	0.00103	CcSEcCtD
Octreotide—Tachycardia—Capecitabine—colon cancer	0.000673	0.00103	CcSEcCtD
Octreotide—Vomiting—Vincristine—colon cancer	0.000673	0.00103	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—colon cancer	0.000671	0.00103	CcSEcCtD
Octreotide—Skin disorder—Capecitabine—colon cancer	0.00067	0.00102	CcSEcCtD
Octreotide—Rash—Vincristine—colon cancer	0.000667	0.00102	CcSEcCtD
Octreotide—Hyperhidrosis—Capecitabine—colon cancer	0.000667	0.00102	CcSEcCtD
Octreotide—Dermatitis—Vincristine—colon cancer	0.000667	0.00102	CcSEcCtD
Octreotide—Headache—Vincristine—colon cancer	0.000663	0.00101	CcSEcCtD
Octreotide—Anorexia—Capecitabine—colon cancer	0.000658	0.00101	CcSEcCtD
Octreotide—Vomiting—Irinotecan—colon cancer	0.000655	0.001	CcSEcCtD
Octreotide—Immune system disorder—Methotrexate—colon cancer	0.000653	0.000998	CcSEcCtD
Octreotide—Dizziness—Fluorouracil—colon cancer	0.000653	0.000998	CcSEcCtD
Octreotide—Rash—Irinotecan—colon cancer	0.00065	0.000994	CcSEcCtD
Octreotide—Dermatitis—Irinotecan—colon cancer	0.000649	0.000993	CcSEcCtD
Octreotide—Headache—Irinotecan—colon cancer	0.000646	0.000987	CcSEcCtD
Octreotide—Alopecia—Methotrexate—colon cancer	0.000639	0.000977	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—colon cancer	0.000633	0.000968	CcSEcCtD
Octreotide—Malnutrition—Methotrexate—colon cancer	0.000629	0.000962	CcSEcCtD
Octreotide—Erythema—Methotrexate—colon cancer	0.000629	0.000962	CcSEcCtD
Octreotide—Nausea—Vincristine—colon cancer	0.000629	0.000961	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000629	0.000961	CcSEcCtD
Octreotide—Vomiting—Fluorouracil—colon cancer	0.000628	0.00096	CcSEcCtD
Octreotide—Insomnia—Capecitabine—colon cancer	0.000624	0.000954	CcSEcCtD
Octreotide—Rash—Fluorouracil—colon cancer	0.000622	0.000952	CcSEcCtD
Octreotide—Dermatitis—Fluorouracil—colon cancer	0.000622	0.000951	CcSEcCtD
Octreotide—Paraesthesia—Capecitabine—colon cancer	0.000619	0.000947	CcSEcCtD
Octreotide—Headache—Fluorouracil—colon cancer	0.000618	0.000945	CcSEcCtD
Octreotide—Dyspnoea—Capecitabine—colon cancer	0.000615	0.00094	CcSEcCtD
Octreotide—Nausea—Irinotecan—colon cancer	0.000612	0.000936	CcSEcCtD
Octreotide—Back pain—Methotrexate—colon cancer	0.000609	0.000931	CcSEcCtD
Octreotide—Dyspepsia—Capecitabine—colon cancer	0.000607	0.000928	CcSEcCtD
Octreotide—Decreased appetite—Capecitabine—colon cancer	0.0006	0.000917	CcSEcCtD
Octreotide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000596	0.000911	CcSEcCtD
Octreotide—Fatigue—Capecitabine—colon cancer	0.000595	0.000909	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—colon cancer	0.000593	0.000907	CcSEcCtD
Octreotide—Constipation—Capecitabine—colon cancer	0.00059	0.000902	CcSEcCtD
Octreotide—Pain—Capecitabine—colon cancer	0.00059	0.000902	CcSEcCtD
Octreotide—Nausea—Fluorouracil—colon cancer	0.000586	0.000896	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—colon cancer	0.000584	0.000893	CcSEcCtD
Octreotide—Anaemia—Methotrexate—colon cancer	0.000582	0.000889	CcSEcCtD
Octreotide—Feeling abnormal—Capecitabine—colon cancer	0.000568	0.000869	CcSEcCtD
Octreotide—Malaise—Methotrexate—colon cancer	0.000567	0.000868	CcSEcCtD
Octreotide—Vertigo—Methotrexate—colon cancer	0.000565	0.000864	CcSEcCtD
Octreotide—Gastrointestinal pain—Capecitabine—colon cancer	0.000564	0.000862	CcSEcCtD
Octreotide—Cough—Methotrexate—colon cancer	0.000549	0.000839	CcSEcCtD
Octreotide—Urticaria—Capecitabine—colon cancer	0.000548	0.000838	CcSEcCtD
Octreotide—Body temperature increased—Capecitabine—colon cancer	0.000545	0.000834	CcSEcCtD
Octreotide—Abdominal pain—Capecitabine—colon cancer	0.000545	0.000834	CcSEcCtD
Octreotide—Convulsion—Methotrexate—colon cancer	0.000545	0.000833	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—colon cancer	0.000536	0.000819	CcSEcCtD
Octreotide—Myalgia—Methotrexate—colon cancer	0.000536	0.000819	CcSEcCtD
Octreotide—Chest pain—Methotrexate—colon cancer	0.000536	0.000819	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000532	0.000813	CcSEcCtD
Octreotide—Discomfort—Methotrexate—colon cancer	0.000529	0.000809	CcSEcCtD
Octreotide—Anaphylactic shock—Methotrexate—colon cancer	0.000514	0.000785	CcSEcCtD
Octreotide—Infection—Methotrexate—colon cancer	0.00051	0.00078	CcSEcCtD
Octreotide—Hypersensitivity—Capecitabine—colon cancer	0.000508	0.000777	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—colon cancer	0.000504	0.00077	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—colon cancer	0.000503	0.000769	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—colon cancer	0.000499	0.000763	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—colon cancer	0.000496	0.000759	CcSEcCtD
Octreotide—Asthenia—Capecitabine—colon cancer	0.000495	0.000757	CcSEcCtD
Octreotide—Anorexia—Methotrexate—colon cancer	0.00049	0.000748	CcSEcCtD
Octreotide—Pruritus—Capecitabine—colon cancer	0.000488	0.000746	CcSEcCtD
Octreotide—Diarrhoea—Capecitabine—colon cancer	0.000472	0.000722	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000468	0.000715	CcSEcCtD
Octreotide—Insomnia—Methotrexate—colon cancer	0.000464	0.00071	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—colon cancer	0.000461	0.000705	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—colon cancer	0.000458	0.0007	CcSEcCtD
Octreotide—Somnolence—Methotrexate—colon cancer	0.000457	0.000698	CcSEcCtD
Octreotide—Dizziness—Capecitabine—colon cancer	0.000456	0.000697	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—colon cancer	0.000452	0.000691	CcSEcCtD
Octreotide—Decreased appetite—Methotrexate—colon cancer	0.000446	0.000682	CcSEcCtD
Octreotide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000443	0.000678	CcSEcCtD
Octreotide—Fatigue—Methotrexate—colon cancer	0.000443	0.000677	CcSEcCtD
Octreotide—Pain—Methotrexate—colon cancer	0.000439	0.000671	CcSEcCtD
Octreotide—Vomiting—Capecitabine—colon cancer	0.000439	0.000671	CcSEcCtD
Octreotide—Rash—Capecitabine—colon cancer	0.000435	0.000665	CcSEcCtD
Octreotide—Dermatitis—Capecitabine—colon cancer	0.000435	0.000664	CcSEcCtD
Octreotide—Headache—Capecitabine—colon cancer	0.000432	0.000661	CcSEcCtD
Octreotide—Feeling abnormal—Methotrexate—colon cancer	0.000423	0.000647	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—colon cancer	0.00042	0.000642	CcSEcCtD
Octreotide—Nausea—Capecitabine—colon cancer	0.00041	0.000626	CcSEcCtD
Octreotide—Urticaria—Methotrexate—colon cancer	0.000408	0.000624	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—colon cancer	0.000406	0.000621	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—colon cancer	0.000406	0.000621	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—colon cancer	0.000378	0.000578	CcSEcCtD
Octreotide—Asthenia—Methotrexate—colon cancer	0.000368	0.000563	CcSEcCtD
Octreotide—Pruritus—Methotrexate—colon cancer	0.000363	0.000555	CcSEcCtD
Octreotide—Diarrhoea—Methotrexate—colon cancer	0.000351	0.000537	CcSEcCtD
Octreotide—Dizziness—Methotrexate—colon cancer	0.00034	0.000519	CcSEcCtD
Octreotide—Vomiting—Methotrexate—colon cancer	0.000327	0.000499	CcSEcCtD
Octreotide—Rash—Methotrexate—colon cancer	0.000324	0.000495	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—colon cancer	0.000324	0.000495	CcSEcCtD
Octreotide—Headache—Methotrexate—colon cancer	0.000322	0.000492	CcSEcCtD
Octreotide—Nausea—Methotrexate—colon cancer	0.000305	0.000466	CcSEcCtD
